Prakash Investment Advisors LLC Acquires 600 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

Prakash Investment Advisors LLC lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 33.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,400 shares of the biotechnology company's stock after acquiring an additional 600 shares during the quarter. Axon Enterprise comprises approximately 1.4% of Prakash Investment Advisors LLC's holdings, making the stock its 15th largest position. Prakash Investment Advisors LLC's holdings in Axon Enterprise were worth $1,262,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Fourth Dimension Wealth LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at about $30,000. Bartlett & CO. Wealth Management LLC lifted its position in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 33 shares during the last quarter. Alpine Bank Wealth Management bought a new stake in Axon Enterprise during the 1st quarter valued at approximately $40,000. Elequin Capital LP acquired a new stake in Axon Enterprise in the 4th quarter valued at approximately $46,000. Finally, CoreFirst Bank & Trust bought a new position in Axon Enterprise in the 4th quarter worth approximately $59,000. 79.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on AXON. Needham & Company LLC increased their price objective on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Bank of America increased their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research note on Wednesday, June 4th. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. The Goldman Sachs Group raised their price objective on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Finally, Barclays boosted their price objective on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and an average price target of $699.55.

Axon Enterprise Price Performance

Shares of NASDAQ AXON traded down $0.83 during midday trading on Wednesday, reaching $774.55. 574,084 shares of the company traded hands, compared to its average volume of 712,624. The firm has a market cap of $60.30 billion, a PE ratio of 187.09, a PEG ratio of 95.30 and a beta of 1.29. The stock's 50-day simple moving average is $725.09 and its 200-day simple moving average is $632.70. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $830.21. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.62 and a current ratio of 2.83.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. During the same period in the previous year, the business earned $1.15 earnings per share. The company's revenue for the quarter was up 31.3% compared to the same quarter last year. As a group, equities analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Michael Garnreiter sold 5,913 shares of the business's stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $760.00, for a total value of $4,493,880.00. Following the completion of the transaction, the director directly owned 17,740 shares of the company's stock, valued at approximately $13,482,400. The trade was a 25.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Brittany Bagley sold 3,400 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the completion of the sale, the chief financial officer directly owned 131,833 shares of the company's stock, valued at approximately $92,283,100. This represents a 2.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 44,642 shares of company stock worth $30,500,428 over the last quarter. Corporate insiders own 5.70% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.